SCHEMBL24422993

SCHEMBL24422993

CC(C)c1ccnc2c1O[C@@H](C(C)C)CN2

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24422996 1.00 HTR2A (0.33) HTR2AHTR2CHTR2B
SCHEMBL24423311 1.00 HTR2A (0.33) HTR2AHTR2CHTR2B
SCHEMBL4895658 0.74 CASR (0.36) HTR2CHTR2B
SCHEMBL24423000 0.71 BRD4 (0.37)
SCHEMBL24423005 0.71 BRD4 (0.37)
SCHEMBL24422994 0.71 BRD4 (0.37)
SCHEMBL16077533 0.70 RET (0.35) HTR2AHTR2CHTR2B
SCHEMBL24422443 0.69 NOS1 (0.35) HTR2AHTR2CHTR2B
SCHEMBL24422998 0.69 NOS1 (0.35) HTR2AHTR2CHTR2B
SCHEMBL24422440 0.69 NOS1 (0.35) HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022098992-A1 USE OF MACROCYCLIC COMPOUNDS IN METHODS OF TREATING CANCER SCORPION THERAPEUTICS, INC. (US) 2022-05-12 WO disclosed